NCT04865133: Efficacy and Safety of COVID-19 Vaccine in Cancer Patients

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be willing to receive COVID-19 vaccination as per standard of care; Patients must be on or planning to start chemotherapy

Comments are closed.

Up ↑